Drug use in equine competition affects horse welfare both through permitted therapeutic use and through prohibited substance abuse, with regulatory frameworks balancing these concerns.
Drug use in equine competition creates complex welfare tensions. Legitimate therapeutic treatment allows horses to compete while recovering from minor issues - beneficial welfare. But masking pain enables compromised horses to perform beyond their physical limits, risking catastrophic injury. The welfare-first principle demands that horses showing significant clinical signs should not compete regardless of medication status. Regulatory frameworks that prioritize horse welfare over competitive advantage - including meaningful penalties for pain-masking violations - protect horses from being used as athletic tools at the expense of their health.